Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Comprehensive Review on Mir-146A Molecular Mechanisms in a Wide Spectrum of Immune and Non-Immune Inflammatory Diseases Publisher Pubmed



Mortazavijahromi SS1 ; Aslani M1 ; Mirshafiey A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Immunology Letters Published:2020


Abstract

MicroRNAs (miRNAs) are single-strand endogenous and non-coding RNA molecules with a length of about 22 nucleotides, which regulate genes expression, through modulating the translation and stability of their target mRNAs. miR-146a is one of the most studied miRNAs, due to its central role in immune system homeostasis and control of the innate and acquired immune responses. Accordingly, abnormal expression or function of miR-146a results in the incidence and progression of immune and non-immune inflammatory diseases. Its deregulated expression pattern and inefficient function have been reported in a wide spectrum of these illnesses. Based on the existing evidence, this miRNA qualifies as an ideal biomarker for diagnosis, prognosis, and activity evaluation of immune and non-immune inflammatory disorders. Moreover, much attention has recently been paid to therapeutic potential of miR-146a and several researchers have assessed the effects of different drugs on expression and function of this miRNA at diverse experimental, animal, besides human levels, reporting motivating results in the treatment of the diseases. Here, in this comprehensive review, we provide an overview of miR-146a role in the pathogenesis and progression of several immune and non-immune inflammatory diseases such as Rheumatoid arthritis, Systemic lupus erythematosus, Inflammatory bowel disease, Multiple sclerosis, Psoriasis, Graves' disease, Atherosclerosis, Hepatitis, Chronic obstructive pulmonary disease, etc., discuss about its eligibility for being a desirable biomarker for these disorders, and also highlight its therapeutic potential. Understanding these mechanisms underlies the selecting and designing the proper therapeutic targets and medications, which eventually facilitate the treatment process. © 2020 European Federation of Immunological Societies
Related Docs
View other Related Docs
1. Efficient Roles of Mir-146A in Cellular and Molecular Mechanisms of Neuroinflammatory Disorders: An Effectual Review in Neuroimmunology, Immunology Letters (2021)
2. Cytokine Storm in the Pathophysiology of Covid-19: Possible Functional Disturbances of Mirnas, International Immunopharmacology (2021)
3. Non-Coding Rna-Mediated Epigenetic Alterations in Grave's Ophthalmopathy: A Scoping Systematic Review, Non-coding RNA Research (2023)
4. The Role of Β-D-Mannuronic Acid, As a New Non-Steroidal Anti-Inflammatory Drug on Expression of Mir-146A, Irak1, Traf6, Nf-Κb and Pro-Inflammatory Cytokines Following a Clinical Trial in Rheumatoid Arthritis Patients, Immunopharmacology and Immunotoxicology (2020)
5. Anti-Inflammatory Micrornas and Their Potential for Inflammatory Diseases Treatment, Frontiers in Immunology (2018)
6. A Systems Biology Approach for Mirna-Mrna Expression Patterns Analysis in Rheumatoid Arthritis, Combinatorial Chemistry and High Throughput Screening (2021)
7. Implications of the Noncoding Rnas in Rheumatoid Arthritis Pathogenesis, Journal of Cellular Physiology (2018)
8. Micrornas in Rheumatoid Arthritis, Clinical Rheumatology (2015)
Experts (# of related papers)
View all Related Experts
Mahdi Mahmoudi (9)
Ahmad Reza Jamshidi (7)
Other Related Docs
9. Pharmacological Effects of Β-D-Mannuronic Acid (M2000) on Mir-146A, Irak1, Traf6 and Nf-Κb Gene Expression, As Target Molecules in Inflammatory Reactions, Pharmacological Reports (2017)
10. Comparison of Plasma Levels of Microrna-155-5P, Microrna-210-3P, and Microrna-16-5P in Rheumatoid Arthritis Patients With Healthy Controls in a Case-Control Study, Iranian Journal of Allergy# Asthma and Immunology (2023)
11. Plasma Levels of Microrna-146A-5P, Microrna-24-3P, and Microrna-125A-5P As Potential Diagnostic Biomarkers for Rheumatoid Arthritis, Iranian Journal of Allergy# Asthma and Immunology (2021)
12. Epigenetics of Autoimmune Diseases, Prognostic Epigenetics (2019)
13. Salivary Level of Microrna-146A and Microrna-155 Biomarkers in Patients With Oral Lichen Planus Versus Oral Squamous Cell Carcinoma, BMC Oral Health (2023)
14. Microrna Signature of Regulatory T Cells in Health and Autoimmunity, Biomedicine and Pharmacotherapy (2018)
15. Epigenetic Modifications and Epigenetic Based Medication Implementations of Autoimmune Diseases, Biomedicine and Pharmacotherapy (2017)
16. Effects of Micro Rnas and Their Targets in Periodontal Diseases, Infectious Disorders - Drug Targets (2018)
17. Dysregulated Mirnas Network in the Critical Covid-19: An Important Clue for Uncontrolled Immunothrombosis/Thromboinflammation, International Immunopharmacology (2022)
18. G2013 Modulates Tlr4 Signaling Pathway in Irak-1 and Tarf-6 Dependent and Mir-146A Independent Manner, Cellular and Molecular Biology (2016)
19. The Rs2910164 Variant Is Associated With Reduced Mir-146A Expression But Not Cytokine Levels in Patients With Type 2 Diabetes, Journal of Endocrinological Investigation (2018)
20. Cell Death Pathways and Viruses: Role of Micrornas, Molecular Therapy Nucleic Acids (2021)
21. Integrational Analysis of Mirnas Data Sets As a Plausible Missing Linker Between Epstein-Barr Virus and Vitamin D in Relapsing Remitting Ms Patients, Gene (2019)
22. Dysregulated Expression of Mir-146A and Its Associated Immune Effectors in Peripheral Blood Mononuclear Cells of Esophageal Carcinoma Patients, Immunological Investigations (2022)
23. Epigenetic Alterations Underlying Autoimmune Diseases, Autoimmunity (2016)
24. Micrornas-Mediated Regulation Pathways in Rheumatic Diseases, Inflammopharmacology (2023)
25. Immunopharmacological Effect of Β-D-Mannuronic Acid (M2000), As a New Immunosuppressive Drug, on Gene Expression of Mir-155 and Its Target Molecules (Socs1, Ship1) in a Clinical Trial on Rheumatoid Arthritis Patients, Drug Development Research (2020)
26. Inhibitory Effect of G2013 Molecule As a Novel Immunomodulatory Agent, on Mir-155 Gene Expression in Hek-Blue Htlr4 Cell Line, European Journal of Inflammation (2016)
27. Application of Nanoparticle Technology in the Treatment of Systemic Lupus Erythematous, Biomedicine and Pharmacotherapy (2016)
28. The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection, International Immunopharmacology (2021)
29. The Inhibitory Role of M2000 (Β-D-Mannuronic Acid) on Expression of Toll-Like Receptor 2 and 4 in Ht29 Cell Line, Recent Patents on Inflammation and Allergy Drug Discovery (2019)
30. Mirna-146A Improves Immunomodulatory Effects of Msc-Derived Exosomes in Rheumatoid Arthritis, Current Gene Therapy (2020)
31. Epigenetic Modifications and Therapy in Multiple Sclerosis, NeuroMolecular Medicine (2017)
32. Epigenetic Involvement in Etiopathogenesis and Implications in Treatment of Systemic Lupus Erythematous, Inflammation Research (2017)
33. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients, Iranian Journal of Allergy# Asthma and Immunology (2022)
34. Micrornas and Diabetes Mellitus Type 1, Current Diabetes Reviews (2022)
35. The Pathogenic, Therapeutic and Diagnostic Role of Exosomal Microrna in the Autoimmune Diseases, Journal of Neuroimmunology (2021)
36. Immunologic Balance of Regulatory T Cell/T Helper 17 Responses in Gastrointestinal Infectious Diseases: Role of Mirnas, Microbial Pathogenesis (2019)
37. The Salivary Exosomal Microrna As a Potential Biomarker in Patients With Periodontitis and Oral Cancers, Chemical Biology and Drug Design (2023)
38. Microrna-155 and Its Exosomal Form: Small Pieces in the Gastrointestinal Cancers Puzzle, Cell Biology and Toxicology (2024)
39. Competing Endogenous Rnas (Cernas): Novel Network in Neurological Disorders, Current Medicinal Chemistry (2021)
40. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
41. Dysregulated Expression of Mirnas in Immune Thrombocytopenia, Epigenomics (2021)
42. Micrornas As Potential Diagnostic, Prognostic, and Predictive Biomarkers for Acute Graft-Versus-Host Disease, Biology of Blood and Marrow Transplantation (2019)
43. Inflammation Related Mirnas As an Important Player Between Obesity and Cancers, Journal of Diabetes and Metabolic Disorders (2019)
44. Epigenetics and Pathogenesis of Systemic Sclerosis; the Ins and Outs, Human Immunology (2018)
45. Microrna Expression Profiles of Peripheral Blood and Mononuclear Cells in Myasthenia Gravis: A Systematic Review, International Immunopharmacology (2022)
46. The Role of Micrornas in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs, Journal of Immunology Research (2020)
47. Exosomal Micrornas As Biomarkers in Allergic Asthma, Iranian Journal of Allergy# Asthma and Immunology (2021)
48. Microrna-146A Induces Immune Suppression and Drug-Resistant Colorectal Cancer Cells, Tumor Biology (2017)
49. Implications of Micrornas in the Pathogenesis of Atherosclerosis and Prospects for Therapy, Current Drug Targets (2021)
50. Role of Exosome in Autoimmunity, With a Particular Emphasis on Rheumatoid Arthritis, International Journal of Rheumatic Diseases (2021)